€76.15
1.53% today
Xetra, Nov 26, 01:14 pm CET
ISIN
DE000A0LD6E6
Symbol
GXI
Index
Industry

Gerresheimer Stock price

€75.00
-7.10 8.65% 1M
-30.80 29.11% 6M
-19.35 20.51% YTD
-12.00 13.79% 1Y
-4.05 5.12% 3Y
+7.35 10.86% 5Y
+30.23 67.52% 10Y
Xetra, Closing price Mon, Nov 25 2024
+1.15 1.56%
ISIN
DE000A0LD6E6
Symbol
GXI
Index
Industry

Key metrics

Market capitalization €2.59b
Enterprise Value €3.77b
P/E (TTM) P/E ratio 22.66
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.87
P/S ratio (TTM) P/S ratio 1.29
P/B ratio (TTM) P/B ratio 1.81
Dividend yield 1.67%
Last dividend (FY23) €1.25
Revenue growth (TTM) Revenue growth 1.93%
Revenue (TTM) Revenue €2.01b
EBIT (operating result TTM) EBIT €227.30m
Free Cash Flow (TTM) Free Cash Flow €-120.48m
Cash position €109.45m
EPS (TTM) EPS €3.31
P/E forward 20.63
P/S forward 1.27
EV/Sales forward 1.84
Show more

Is Gerresheimer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Gerresheimer Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Gerresheimer forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a Gerresheimer forecast:

Buy
94%
Hold
6%

Financial data from Gerresheimer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
2,012 2,012
2% 2%
100%
- Direct Costs 1,427 1,427
4% 4%
71%
585 585
2% 2%
29%
- Selling and Administrative Expenses 145 145
1% 1%
7%
- Research and Development Expense 19 19
0% 0%
1%
422 422
3% 3%
21%
- Depreciation and Amortization 194 194
3% 3%
10%
EBIT (Operating Income) EBIT 227 227
8% 8%
11%
Net Profit 114 114
6% 6%
6%

In millions EUR.

Don't miss a Thing! We will send you all news about Gerresheimer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Gerresheimer Stock News

EQS
about one month ago
Über Gerresheimer  Gerresheimer ist als innovativer System- und Lösungsanbieter der globale Partner für die Pharma-, Biotech-und Kosmetikbranche. Das Unternehmen bietet ein umfassendes Portfolio von Containment Solutions für Medikamente, Drug-Delivery-Systemen und Medizinprodukten sowie Lösungen ...
AD HOC NEWS
about one month ago
Gerresheimer AG / DE000A0LD6E6
AD HOC NEWS
about one month ago
Gerresheimer AG / DE000A0LD6E6
More Gerresheimer News

Company Profile

Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices; Primary Packaging Glass; and Head Office. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The company was founded on November 3, 2004 and is headquartered in Duesseldorf, Germany.

Head office Germany
CEO Dietmar Siemssen
Employees 11,660
Founded 1864
Website www.gerresheimer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today